FIELD: biotechnology, more particularly chemistry of steroids. SUBSTANCE: invention describes process for preparing 17-oxosteroids by enzymic oxidation of 17-hydroxysteroids which comprises using bacterial culture Mycobacterium spec. NRRL B-3683. The initial sources include 3.3-(2.2-dimethyl trimethylenedioxy)-5,10- α-epoxy-5-a-ether-9(11)ene-17-b-ol or a-equilol. EFFECT: more efficient preparation process. 2 cl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREPARATION OF 4-ANDROSTENE-3,17-DIONE OR 1,4-ANDROSTADIENE-3,17-DIONE | 0 |
|
SU1679977A3 |
| PROCESS FOR PRODUCING DERIVATIVES OF ANDROSTANE-17-ONE | 0 |
|
SU980628A3 |
| METHOD OF PREPARING 21-OXY-20-METHYLPREGNANE DERIVATIVES | 0 |
|
SU862830A3 |
| 19,11-BRIDGED OVER 4-ESTRENES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, INTERMEDIATE COMPOUNDS | 1993 |
|
RU2157814C2 |
| METHOD OF TUMOR METASTASIS TREATMENT | 1990 |
|
RU2112514C1 |
| METHOD OF MANUFACTURING ANDROST-1,4-DIENE-3,17-DIONE | 1993 |
|
RU2039824C1 |
| 0 |
|
SU514573A3 | |
| AGENT FOR PLATELET AGGREGATION DELAYING | 1992 |
|
RU2097039C1 |
| PROCESS FOR PRODUCING 11 BETA-HYDROXYSTEROIDS | 0 |
|
SU940650A3 |
| 0 |
|
SU468409A3 |
